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Abstract Objectives: Recommen-
dations for EEG monitoring in the
ICU are lacking. The Neurointensive
Care Section of the ESICM assem-
bled a multidisciplinary group to
establish consensus recommendations
on the use of EEG in the ICU.
Methods: A systematic review was
performed and 42 studies were
included. Data were extracted using
the PICO approach, including:
(a) population, i.e. ICU patients with
at least one of the following: trau-
matic brain injury, subarachnoid
hemorrhage, intracerebral hemor-
rhage, stroke, coma after cardiac
arrest, septic and metabolic encepha-
lopathy, encephalitis, and status
epilepticus; (b) intervention, i.e. EEG
monitoring of at least 30 min dura-
tion; (c) control, i.e. intermittent vs.
continuous EEG, as no studies com-
pared patients with a specific clinical
condition, with and without EEG
monitoring; (d) outcome endpoints,
i.e. seizure detection, ischemia
detection, and prognostication. After
selection, evidence was classified and
recommendations developed using
the GRADE system. Recommenda-
tions: The panel recommends EEG
in generalized convulsive status epi-
lepticus and to rule out nonconvulsive
seizures in brain-injured patients and
in comatose ICU patients without
primary brain injury who have unex-
plained and persistent altered
consciousness. We suggest EEG to
detect ischemia in comatose patients
with subarachnoid hemorrhage and to
improve prognostication of coma
after cardiac arrest. We recommend
continuous over intermittent EEG for
refractory status epilepticus and sug-
gest it for patients with status
epilepticus and suspected ongoing
seizures and for comatose patients
with unexplained and persistent
altered consciousness. Conclu-
sions: EEG monitoring is an
important diagnostic tool for specific
indications. Further data are neces-
sary to understand its potential for
ischemia assessment and coma
prognostication.
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Introduction
Acute brain dysfunction is a leading cause of admission to
the ICU, either due to structural diseases, for example
traumatic brain injury (TBI), intracranial hemorrhage,
cerebral ischemia and encephalitis, or to functional
disorders, for example septic encephalopathy. Electroen-
cephalography (EEG) provides information about brain
electrical activity, even when brain function is depressed
and cannot be explored otherwise, as in comatose patients.
EEG is essential to detect electrical seizures and to doc-
ument their duration and response to therapy. It can
disclose alterations associated with the development of
delayed cerebral ischemia (DCI) and improve coma
prognostication. It is useful to monitor barbiturate coma
for refractory intracranial hypertension [1] and is manda-
tory in several countries for the diagnosis of brain death
[2].
Evidence, however, is sparse, and recommenda-
tions for EEG monitoring in the ICU are not well
defined. The Neurointensive Care (NIC) Section of
the ESICM assembled a multidisciplinary panel to
establish a consensus statement on the use of EEG
monitoring in adult ICU populations. The aim was to
provide better guidance for EEG monitoring and to
improve implementation of EEG in ICU practice. Two
indications were excluded from this review: EEG for
brain death diagnosis, since it is regulated by local
legislation in many countries, and for barbiturate
coma, since it has been reviewed in authoritative
guidelines [1].
Methods
Authors and study selection
In 2010, the NIC section of the ESICM decided to
develop evidence-based consensus recommendation on
the indications for EEG monitoring for ICU patients.
Authors were proposed during an official NIC section
meeting and included neurointensivists (N.S., J.C.),
medical/surgical intensivists (F.S.T., M.O.), anesthesiol-
ogists (N.S.), neurologists (J.C.), neurosurgeons (P.H.)
and epileptologists (M.H.) who would review the existing
literature and provide a consensus manuscript. This sys-
tematic review was reported following the PRISMA
criteria [3].
Eligibility criteria
Studies were considered eligible based on the PICO
approach, which includes:
(a) Population, i.e. ICU patients with at least one of the
following: TBI, subarachnoid hemorrhage (SAH),
intracerebral hemorrhage (ICH), acute ischemic
stroke (AIS), coma after cardiac arrest (CA), sepsis/
metabolic encephalopathy, encephalitis, and status
epilepticus (SE).
(b) Intervention, i.e. EEG monitoring of [30 min
duration.
(c) Controls, i.e. intermittent vs. continuous EEG, as no
studies compared patient population with a specific
clinical condition with and without EEG.
(d) Outcome endpoints, i.e. seizure detection, ischemia
detection, prognostication.
Search strategy
Using the PubMed database, we conducted a systematic
review from 1966 up to August 2012. The search
strategy included the terms ‘‘EEG’’ or ‘‘electroencepha-
logram’’ or ‘‘electroencephalography’’, used with one of
the following: ‘‘intensive care’’ or ‘‘critical care’’ or
‘‘ischemia’’ or ‘‘prognosis’’ or ‘‘outcome’’ or ‘‘traumatic
brain injury’’ or ‘‘subarachnoid hemorrhage’’ or ‘‘intra-
cerebral hemorrhage’’ or ‘‘stroke’’ or ‘‘cardiac arrest’’ or
‘‘sepsis’’ or ‘‘metabolic encephalopathy’’ or ‘‘encephali-
tis’’ or ‘‘meningitis’’ or ‘‘status epilepticus’’. Additional
references for relevant studies were also searched from
review articles. We restricted the language of the articles
to English. No unpublished data or congress abstracts
were considered.
Study selection
Two authors (M.O. and F.S.T.) independently reviewed
citations, abstracts and full-text articles to select eligible
studies. We excluded: (a) review articles, (b) case reports,
(c) experimental studies, (d) studies in pediatric ICU
populations, (e) studies that were not conducted on ICU
patients. Data were abstracted (F.S.T.) according to the
PICO system. No attempt was made to re-analyze the
data; accuracy of data extraction was controlled thereafter
(M.O.). No additional process to obtain data from inves-
tigators was attempted. Considering the lack of
randomized or case-control studies, no meta-analysis of
extracted data was performed nor did we assess risk of
bias or consistency, or perform subgroup analyses.
Grading of evidence
The quality of evidence was judged based on the grades
of recommendation, assessment, development and eval-
uation (GRADE) system, which assesses the quality of
evidence for each of the selected outcomes from the
1338
available studies, considering the benefit/risk balance and
the costs related to the study intervention [4, 5]. This
system classifies quality of evidence as high (grade A),
moderate (grade B), low (grade C), or very low (grade D)
[6, 7]. Thereafter, recommendations are classified as
strong (grade 1) or weak (grade 2). One advantage of the
GRADE system is that a strong recommendation can be
made despite moderate/low evidence. Accordingly, the
authors made strong recommendations when they were
confident that the desirable effects of adherence to a
recommendation would outweigh the undesirable effects.
A strong recommendation reflects the possibility that
following the given recommendation about EEG will
result in more beneficial effects (detection and therapy of
seizures, reduced injury associated with ongoing seizures,
improved outcome, less burden on staff and patients, cost
savings) than harm to ICU patients (inaccurate predictive
value, useless antiepileptic drugs (AED), difficult EEG
implementation). A weak recommendation reflects the
opinion that the benefit/risk balance could be in favor of
this recommendation, but the members of the task force
were not confident because of limited evidence. Three
authors (M.O., F.S.T., J.C.) proposed initial recommen-
dations and asked for approval from the other
participants. In case of disagreement, changes to recom-
mendations were proposed and discussed to obtain a
unanimous vote. It is important to recognize that strong
recommendations do not necessarily represent standards
of care.
Results
A total of 42 studies were selected (Fig. 1). All were
retrospective or prospective observational single-center
studies. No controlled trial—either nonrandomized or
randomized—was identified (Table 1). Strong recom-
mendations for EEG use, when given in the absence of
high-quality evidence, are justified by the potential harm
of unrecognized seizures and the low risk of the proce-
dure; however, costs may be considerable and have to be
weighed against the benefit. A summary of GRADE
recommendations for the indications for EEG monitoring
in the ICU is given in Table 2.
Patient populations
EEG in patients with generalized convulsive SE
Seizure detection Generalized convulsive SE (GCSE) is
a clinical diagnosis that does not require EEG. However,
nonconvulsive seizures (NCSz) and nonconvulsive SE
(NCSE) are frequent (48 % and 14 %, respectively) after
GCSE [8] and differentiating ongoing seizure activity
from postictal or medication-induced encephalopathy can
be challenging. As clinical symptoms are often missing,
EEG is necessary to diagnose ongoing NCSz [9, 10].
EEG, especially continuous EEG (cEEG), is urgently
required in patients not waking up after cessation of
clinical seizures to rule out NCSz [8, 11]. Guidelines for
Fig. 1 Flow-chart representing
the methodology for the
systematic review, according to
the PRISMA criteria
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the management of SE in the ICU have recently been
published [6].
Recommendations for patients with convulsive SE
1. We recommend urgent EEG in patients with SE that
do not return to functional baseline within 60 min after
administration of seizure medication (strong recom-
mendation, low quality of evidence—grade 1C).
EEG in patients with refractory SE
SE resistant to initial therapy, also known as refractory SE
(RSE), is almost exclusively nonconvulsive and requires
initiation of intravenous AED [12–14]. CEEG is required
to guide therapy for RSE, aiming to stop ongoing elec-
trographic seizures. One study showed that although RSE
initially responded to intravenous therapy, many patients
subsequently developed NCSz, detectable only with
cEEG [15]. There is controversy as to the minimum
duration of monitoring [16–19] (see section ‘‘Techno-
logical issues’’). Video-cEEG monitoring helps with the
interpretation of complex electrographic abnormalities,
but its efficacy over standard EEG has not been demon-
strated yet [20].
Recommendations for patients with refractory SE
1. We recommend urgent (within 60 min) EEG in
patients with RSE (strong recommendation, low
quality of evidence—grade 1C).
EEG in patients with TBI
Seizure detection Patients suffering from TBI are at risk
of NCSz [21, 22]. Risk factors for NCSz are depressed
skull fracture, penetrating injury and large cortical con-
tusion/hematomas [22]. Observational studies in patients
with TBI monitored by EEG have shown a variable
prevalence of NCSz. Vespa et al. (n = 90 patients,
duration of cEEG 7 days) found a 22 % prevalence of
seizures, of which 52 % were NCSz, despite AED pro-
phylaxis [19]. Ronne-Engstrom and Winkler studied 70
patients (duration of cEEG 58 h, no AED prophylaxis)
and found a 33 % prevalence of seizures (starting on
average 74 h after TBI), the majority of which were
NCSz [23]. The frequency of NCSz depends on the
amount of sedatives used. Two recent studies, in which
patients were given high sedative doses with intrinsic
antiseizure activity, showed no [24] or a very low (3 %)
[25] rate of NCSz. NCSz are associated with intracranial
pressure elevations [26], increased cerebral metabolic
distress [26] and long-term hippocampal atrophy [27].T
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Despite variable results and lack of multicenter studies,
there is a strong rationale for EEG monitoring after TBI.
This is reinforced by the fact that primary AED prophy-
laxis is frequently unreliable in preventing or suppressing
NCSz [28].
Ischemia detection No study has shown a role for EEG
in detecting ischemia after TBI.
Prognostication Towne et al. [29] and Vespa et al. [19]
were unable to demonstrate a difference in mortality
between TBI patients with or without EEG seizures. EEG
reactivity to auditory or nociceptive stimuli predicted
good outcome after TBI, whereas absent EEG reactivity
resulted in a poor outcome [30, 31] with a higher pre-
dictive value than GCS and somatosensory evoked
potentials. In another study, EEG performed daily during
the first week after admission reliably predicted outcome
in 40/50 patients; however, prognosis could not be
assessed in patients with alpha pattern coma or in those
receiving barbiturate therapy [32]. Reduced percentage of
alpha variability also predicted outcome in TBI patients
with GCS B8 (positive predictive value 86 %) [33].
Recommendations for patients with TBI
1. We recommend EEG in all TBI patients with unex-
plained and persistent altered consciousness (strong
recommendation, low quality of evidence—grade 1C).
2. We suggest EEG to rule out NCSz in patients with TBI
and GCS B8, particularly in those with large cortical
contusion/hematoma, depressed skull fracture or
penetrating injury (weak recommendation, low quality
of evidence—grade 2C).
EEG in patients with SAH
Seizure detection Acute seizures have been reported in
between 3 % and 26 % of patients with comatose SAH
[34–36]. Of those undergoing cEEG in the ICU, 3–19 %
Table 2 GRADE recommendations for the indications for EEG in the ICU
GRADE recommendations Patient description Objective
Direction Strength Level of
evidence
Underlying etiology Scenario
Pro Strong
(1)
Low quality
(C)
Generalized convulsive status
epilepticus
No return to functional baseline
after initial antiepileptic therapy
Detect nonconvulsive
seizures
Pro Strong
(1)
Low quality
(C)
Refractory status epilepticus Concern for ongoing seizure
activity
Detect nonconvulsive
seizures
Pro Strong
(1)
Low quality
(C)
Traumatic brain injury Unexplained alteration in
consciousnessa
Detect nonconvulsive
seizures
Pro Strong
(1)
Low quality
(C)
Subarachnoid hemorrhage Unexplained alteration in
consciousnessa
Detect nonconvulsive
seizures
Pro Strong
(1)
Low quality
(C)
Intracerebral hemorrhage Unexplained alteration in
consciousnessa
Detect nonconvulsive
seizures
Pro Strong
(1)
Low quality
(C)
Cardiac arrest Persistent coma Detect nonconvulsive
seizures
Pro Strong
(1)
Low quality
(C)
Encephalitis Unexplained alteration in
consciousnessa
Detect nonconvulsive
seizures
Pro Strong
(1)
Low quality
(B)
Comatose patients without
primary brain injury
Unexplained alteration in
consciousnessa
Detect nonconvulsive
seizures
Pro Weak
(2)
Low quality
(C)
Severe traumatic brain injury Concern for ongoing seizure activity
in high-risk patients (large cortical
hemorrhagic contusion/hematoma)
Detect nonconvulsive
seizures
Pro Weak
(2)
Very low
quality (D)
Acute ischemic stroke Unexplained alteration in
consciousnessa
Detect nonconvulsive
seizures
Pro Weak
(2)
Low quality
(C)
Subarachnoid hemorrhage Patients in whom clinical
examination is unreliable
Detect ischemia
Pro Weak
(2)
Low quality
(C)
Cardiac arrest Persistent coma Prognostication
Pro Weak
(2)
Low quality
(C)
All comatose ICU patients Unexplained alteration in
consciousnessa
Prognostication
Pro Weak
(2)
Very low
quality (D)
Encephalitis Unexplained alteration in
consciousnessa
Prognostication
a Unexplained alteration in consciousness: reduced consciousness state that is not attributable to metabolic disorders (sodium, calcium,
glucose, ammonium, urea), organ dysfunction (hypotension, hypoxemia, sepsis, hyperthermia) or structural brain lesions on imaging
(cerebral CT scan) tests
1343
have NCSz and 13 % have NCSE, which cannot be
diagnosed without EEG. Risk factors for seizures include
older age, poor clinical grade, large intraparenchymal
hemorrhage, large amount of cisternal blood, DCI, and
anterior circulation aneurysm. Seizures may be less likely
in patients that have undergone coil embolization of the
aneurysm [34].
Ischemia detection In SAH patients, changes in EEG
trends on cEEG (performed on days 2–10) correlate with
DCI [37–41]. A number of quantitative EEG (qEEG)
parameters may be useful, including changes in total
power, alpha/delta ratio (ADR), composite alpha index,
and relative alpha variability. There is controversy over
which parameter is best, but all fundamentally relate to
fast to slow frequencies. QEEG can detect EEG changes
associated with DCI 24–48 h prior to other diagnostic
tools [39, 41]. Reported sensitivity is variable but can be
as high as 90 % [37, 38], with 75 % specificity [37], and
100 % negative predictive value and 76 % positive pre-
dictive value [41].
Prognostication Epileptiform discharges or NCSE and
absent EEG background reactivity was associated with
poor prognosis after SAH [42]. Despite this association,
there are no unequivocal human data indicating that
NCSz are causally linked to poor functional outcome or
that treatment improves outcome [34, 35, 42]. Progressive
deterioration on the basis of EEG (increased delta pattern)
was associated with an increased risk of dying by almost
24 % compared to patients whose condition did not
worsen according to EEG [43].
Recommendations for patients with SAH
1. We recommend EEG to rule out NCSz in all SAH
patients with unexplained and persistent altered con-
sciousness (strong recommendation, low quality of
evidence—grade 1C).
2. We suggest EEG to detect DCI in comatose SAH
patients, in whom neurological examination is unreli-
able (weak recommendation, low quality of
evidence—grade 2C).
EEG in patients with ICH
Seizure detection Seizures are seen in 3–17 % of ICH
patients, occurring at 1 day (50–70 %) up to 3 days from
ICH. Most seizures diagnosed in the ICU are non-con-
vulsive (NCSz 53–76 %, NCSE 39 %) and can only be
diagnosed by EEG [44–46]. Risk factors include cortical
bleeding and arteriovenous malformations [44, 46].
Ischemia detection No study has provided data on
ischemia detection in ICH patients.
Prognostication Seizures are associated with an
increase in ICH volume and worsening midline shift [44,
46]. NCSZ worsen neurological status, but an indepen-
dent association with outcome has not been demonstrated
[44, 46].
Recommendations for patients with ICH
1. We recommend EEG to rule out NCSz in all ICH
patients with unexplained and persistent altered con-
sciousness (strong recommendation, low quality of
evidence—grade 1C).
EEG in patients with AIS
Seizure detection One single-center study in which
cEEG was performed in 177 patients with AIS showed a
7 % incidence of seizures (more than 70 % NCSz) in the
acute (\24 h) phase [45]. Seizures are less frequent than
in ICH, SAH or TBI patients.
Ischemia detection A decrease in cerebral perfusion
pressure (CPP) may be associated with a concomitant
reduction in faster EEG activity on qEEG [47], while
rapid improvements in background EEG activity have
been observed upon CPP/CBF increase following man-
nitol therapy [48] or hemodilution [49].
Prognostication Following hemicraniectomy for space-
occupying middle cerebral artery infarction, the presence
of faster EEG activity was associated with good recovery
in patients monitored with cEEG [50]. Three studies have
demonstrated that the disappearance or further slowing of
delta activity in the acute phase (within 24 h) of AIS
predicted a malignant course (cerebral edema) [51–53].
Preliminary studies showed a correlation between the
neurological score in the acute stage of AIS and the
degree of EEG abnormality [54], although this correlation
was shown to be low by others [55]. CEEG improves
outcome prognostication in AIS [56–59]: in particularly,
the ADR and the so-called EEG brain symmetry index are
significantly correlated with outcome at 6 months [56–
59].
Recommendations for patients with AIS
1. We suggest EEG to rule out NCSz in all AIS patients
with unexplained and/or persistently altered con-
sciousness (weak recommendation, very low quality of
evidence—grade 2D).
2. We do not recommend EEG to detect cerebral
ischemia and target CPP in AIS patients (weak
recommendation against, very low quality of evi-
dence—grade 2D).
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3. We do not recommend EEG to detect herniation in
AIS patients (weak recommendation against, very low
quality of evidence—grade 2D).
EEG in patients with coma after CA
Seizure detection Seizures occur in 10–30 % of patients
with coma after CA [60–63]. EEG is required to detect
seizures as most seizures after CA are nonconvulsive and
to differentiate myoclonic SE from peripheral or sub-
cortical myoclonus. When therapeutic hypothermia (TH)
is applied, seizures can occur during TH and after
rewarming [60, 61, 63]. ‘‘Early’’ seizures, occurring dur-
ing TH under sedation, are an ominous sign [60–63].
‘‘Late’’ seizures, occurring after TH and off sedation, carry
a poor prognosis but may respond to therapy in certain
cases [64]: EEG is indicated to titrate therapy [61, 64].
Ischemia detection No study has provided data on
ischemia detection in comatose CA patients or used EEG
to target blood pressure management.
Prognostication Previous to TH, a number of studies
showed that adding EEG—performed at 72 h from CA—
to standard neurological examination improved outcome
prognostication after CA [65–84]. EEG findings associ-
ated with a poor prognosis included spontaneous burst
suppression or generalized periodic discharges. Synek
analyzed EEG background activity (continuous vs. dis-
continuous pattern) and EEG background reactivity to
auditory and painful stimulation, subsequently dichoto-
mized as ‘‘reactive’’ vs. ‘‘non-reactive’’ [30, 80, 85]: the
presence of a continuous and reactive EEG background
(i.e. a change in EEG frequency and amplitude following
stimulation) was associated with good prognosis. At this
time TH is considered the standard of care after CA.
Hypothermia and sedation used during cooling alter
motor response and decrease the prognostic accuracy of
neurological examination. Several studies performed in
patients treated with TH demonstrated that EEG improves
prognostic prediction of coma after CA [63, 86–95]. The
presence of discontinuous and burst-suppression patterns,
and of nonreactive EEG background, were strongly cor-
related (false-positive rates for poor prognosis \10 %)
with a poor prognosis, whilst a continuous reactive
background was associated with good recovery. Impor-
tantly, in some studies, coma prognostication could be
achieved during TH [63, 92, 93].
Recommendations for comatose patients after CA
1. We recommend EEG during TH and within 24 h after
rewarming to rule out NCSz in all comatose patients
after CA (strong recommendation, low quality of
evidence—grade 1C).
2. We suggest EEG to assist with prognostication of
coma after CA, particularly in patients treated with TH
(weak recommendation, low quality of evidence—
grade 2C).
EEG in patients with infectious and non-infectious
encephalitis
Seizure detection Central nervous system (CNS) infec-
tions, mainly acute meningitis/encephalitis, are a risk
factor for seizures, ranging from 6–12 % in some studies
[96], and seizures are associated with higher mortality
rates [97]. In a small retrospective study, Carrera et al.,
found seizures in one-third of 42 patients with primary
CNS infections, and the majority of these were NCSz
[98]. In the large cohort of patients undergoing cEEG
monitoring reported by the Columbia University group,
CNS infections and metabolic encephalopathy accounted
for 13 % of all patients and there was 23 % and 12 %
frequency of NCSE and NCSz, respectively. Comatose
patients needed more than 24 h of cEEG monitoring to
detect NCSz [17]. In another large cohort of neurocritical
care patients (n = 393) with admission GCS B12 and at
least one EEG (cEEG, n = 34), the prevalence of NCSz
was 13 % and was highest among those with CNS
infection, together with anoxic encephalopathy [99].
NCSz are very frequent in noninfectious encephalitis (up
to 78 % of cases) and are mostly nonconvulsive [100].
Ischemia detection No study has provided data on
ischemia detection in patients with encephalitis.
Prognostication No study has analyzed the prognostic
accuracy of EEG in patients with encephalitis but par-
ticular patterns such as ‘‘delta brush’’ may be associated
with a more prolonged illness [100].
Recommendations for patients with infectious and non-
infectious encephalitis
1. We recommend EEG in patients with encephalitis that
are comatose or have unexplained neurological deficits
to rule out NCSz (strong recommendation, low quality
of evidence—grade 1C).
2. We suggest EEG in patients with encephalitis to assist
with prognosis (weak recommendation, very low
quality of evidence—grade 2D).
EEG in comatose ICU patients without acute primary
brain injury
Seizure detection In a retrospective cohort of 238 gen-
eral ICU comatose patients in whom EEG was performed,
Towne et al. found a prevalence of NCSz of 8 % [29].
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Postanoxic encephalopathy (42 %) was the most common
etiology, followed by AIS (22 %), CNS infection, TBI,
metabolic encephalopathy, alcohol or AED withdrawal
(5 %), and brain tumor (all 5 %). Using standard 20-min
EEG, Scozzafava found NCSz only in 2 of 169 patients
with GCS \8 [101]. In 286 patients, of whom 22 % had
encephalitis and 24 % metabolic encephalopathy, Firosh
Khan et al. found that 4 % had NCSE and 10 % NCSz
[102]. Patients with primary brain injury had a higher
incidence of NCSz than those with metabolic encepha-
lopathy (32 % vs. 4 %) [103]. Only two studies
specifically focused on patients admitted to the ICU
without a primary acute brain condition, in whom cEEG
was performed because of altered consciousness. Young
et al. found no NCSz among 62 patients with sepsis [104].
In a retrospective cohort of 201 medical ICU patients
monitored with cEEG, Oddo et al. found a 10 % fre-
quency of seizures, of which 69 % were purely NCSz
[105]. Sepsis was the most common etiology and was the
only independent risk factor for seizures. These findings
confirm those of previous studies showing that septic
encephalopathy and metabolic dysfunction (mainly renal
and hepatic failure) are risk factors for NCSz [11, 106,
107].
Ischemia detection No study has provided data on
ischemia detection in medical/surgical ICU populations.
Prognostication Patients with NCSz had the highest
mortality rate in a large neuro-ICU population, although
this finding was not significant after adjustment for con-
founding factors [99]. The same results were found in
another study [101]. Firosh Khan et al. [102] found 42 %
and 21 % of patients with NCSE and NCSz, respectively,
had a poor outcome, but did not analyze the prognostic
value of these findings. Young et al. [108] found that EEG
suppression and lack of EEG reactivity were associated
with a worse outcome in ICU patients; however, these
data were only applicable to comatose CA patients. In a
study of septic patients, the same group found that EEG
abnormalities, but not NCSz, were associated with mor-
tality (0 % in patients with normal EEG, 19 % in patients
with theta rhythm, 36 % in patients with delta rhythm,
50 % in patients with triphasic waves and 67 % in
patients with suppression) [104]. NCSz was associated
with a poor outcome in septic patients [105] and in crit-
ically ill elderly ([65 years of age) patients [109].
Recommendations for comatose ICU patients
without acute primary brain injury
1. We suggest EEG in comatose ICU patients without an
acute primary brain condition and with unexplained
impairment of mental status or unexplained neuro-
logical deficits to rule out NCSz, particularly in those
with severe sepsis or renal/hepatic failure (weak rec-
ommendation, low quality of evidence—grade 2C).
Technological issues
Duration of monitoring: continuous vs. intermittent EEG
monitoring
Seizure detection Continuous EEG allows the detection
of NCSz [11, 18, 103, 110] but there is controversy as to
the minimum duration of cEEG. In a single-center retro-
spective study, about 50 % of NCSz were detected within
the first 60 min of EEG, but in comatose neuro-ICU
patients at least 24 h and up to 48 h of monitoring may be
required [17]. Continuous EEG is essential to titrate AED
in RSE and to identify recurrent NCSz [15]. Intermittent
(\30 min duration) EEG may be insufficiently sensitive
to detect NCSz [101], but no studies have compared
continuous to intermittent EEG. Standard EEG can pro-
vide useful information in selected clinical situations,
such as epilepsy-related situations, CA and brain death
examination [102, 111]. In a recent study, independent
predictors of epileptiform activity included a history of
convulsive seizure(s), increasing age, deeper coma, and
female gender [99]. In this study, the ‘‘number needed to
monitor’’ was seven, i.e. at least seven neuro-ICU patients
should undergo intermittent EEG to diagnose one with
seizures.
Ischemia detection Continuous EEG using qEEG anal-
ysis has been used to detect cerebral ischemia in comatose
SAH patients and in subjects with AIS. In SAH patients at
risk of DCI, monitoring is performed for several days,
during maximum DCI risk [37, 39, 41], and on average
for 7 days [39]. QEEG is similarly performed for several
days after AIS, one study reporting an average of 83 h of
monitoring [47].
Prognostication After CA and TH, EEG—intermittent
or continuous—improves coma prognostication [63, 86–
95, 112]. Whether cEEG has higher prognostic accuracy
than intermittent EEG has not been evaluated. Early
prognostication of AIS [56–59], ICH [44, 46] and SAH
[42] has exclusively been assessed with cEEG.
Recommendations for continuous EEG over intermittent
EEG monitoring
1. We recommend cEEG for seizure detection in patients
with RSE (strong recommendation, low quality of
evidence—grade 1C).
2. We suggest cEEG for seizure detection in patients with
SE that do not return to functional baseline within
60 min after administration of seizure medication
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(weak recommendation, low quality of evidence—
grade 2C).
3. We suggest cEEG for seizure detection in comatose
ICU patients (TBI, SAH, ICH, coma after CA,
encephalitis, and septic and metabolic encephalopathy)
with unexplained and persistent altered consciousness
(weak recommendation, low quality of evidence—
grade 2C).
4. We suggest cEEG for ischemia detection in comatose
SAH patients in whom neurological examination is
unreliable (weak recommendation, low quality of
evidence—grade 2C).
5. We suggest cEEG to assist with prognostication of
coma after CA (weak recommendation, low quality of
evidence—grade 2C).
Montage: standard vs. simplified
Seizure detection The placement of 21 electrodes is the
standard method for EEG monitoring. Compared to
standard EEG, the sensitivities of simplified EEG for
seizure detection were 93 % in one study using seven
electrodes [113], 68 % in another study using four elec-
trodes [114], and 40 % with single-channel EEG [115].
Ischemia detection All studies that examined the value
of EEG for ischemia detection used a standard montage
[37, 39, 41, 47].
Prognostication After CA and TH, EEG—intermittent
or continuous—improves coma prognostication. The
majority of the studies used a standard EEG montage [86,
88–92, 94, 95, 112], but others showed similar predictive
values using simplified montages [63, 87, 93]. Prognos-
tication of AIS [56–59], ICH [44, 46] and SAH [42] has
exclusively been assessed with a standard montage.
Recommendations for standard vs. simplified EEG
montage in ICU patients
1. We recommend a standard EEG montage (21 elec-
trodes) for the detection of NCSz in ICU patients
(weak recommendation, poor quality of evidence—
grade 2C).
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